Sensitive genotyping of mutations in the EGFR gene from NSCLC patients using PCR-GoldMag lateral flow device

Abstract Epidermal growth factor receptor (EGFR) mutations predict better outcomes with EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). Most common activating mutations include in-frame deletion in exon 19 and L858R substitution in exon 21, which account for >...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xian-Ying Li, Chao Zhang, Qin-Lu Zhang, Juan-Li Zhu, Qian Liu, Ming-Wei Chen, Xue-Min Yang, Wen-Li Hui, Ya-Li Cui
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ac6a5c9980654cd8ab230d3fecbc3679
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!